The global market for Anti-inflammatory Medicine for Pets was estimated to be worth US$ 1152 million in 2023 and is forecast to a readjusted size of US$ 1723.5 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

Anti-inflammatory Medicine for Pets - Market

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Medicine for Pets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-inflammatory Medicine for Pets by region & country, by Type, and by Application.

The Anti-inflammatory Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Medicine for Pets.

Market Segmentation

Scope of Anti-inflammatory Medicine for Pets - Market Report

Report Metric	Details
Report Name	Anti-inflammatory Medicine for Pets - Market
Forecasted market size in 2030	US$ 1723.5 million
CAGR	6.0%
Forecasted years	2024 - 2030
Segment by Type:	Powder Liquid
Segment by Application	Cat Dog Reptile Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-inflammatory Medicine for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-inflammatory Medicine for Pets in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Anti-inflammatory Medicine for Pets - Market size in 2030?

Ans: The Anti-inflammatory Medicine for Pets - Market size in 2030 will be US$ 1723.5 million.

What is the Anti-inflammatory Medicine for Pets - Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Anti-inflammatory Medicine for Pets - Market report?

Ans: The main players in the Anti-inflammatory Medicine for Pets - Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC

What are the Application segmentation covered in the Anti-inflammatory Medicine for Pets - Market report?

Ans: The Applications covered in the Anti-inflammatory Medicine for Pets - Market report are Cat, Dog, Reptile, Other

What are the Type segmentation covered in the Anti-inflammatory Medicine for Pets - Market report?

Ans: The Types covered in the Anti-inflammatory Medicine for Pets - Market report are Powder, Liquid

1 Market Overview

1.1 Anti-inflammatory Medicine for Pets Product Introduction

1.2 Global Anti-inflammatory Medicine for Pets Market Size Forecast

1.2.1 Global Anti-inflammatory Medicine for Pets Sales Value (2019-2030)

1.2.2 Global Anti-inflammatory Medicine for Pets Sales Volume (2019-2030)

1.2.3 Global Anti-inflammatory Medicine for Pets Sales Price (2019-2030)

1.3 Anti-inflammatory Medicine for Pets Market Trends & Drivers

1.3.1 Anti-inflammatory Medicine for Pets Industry Trends

1.3.2 Anti-inflammatory Medicine for Pets Market Drivers & Opportunity

1.3.3 Anti-inflammatory Medicine for Pets Market Challenges

1.3.4 Anti-inflammatory Medicine for Pets Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-inflammatory Medicine for Pets Players Revenue Ranking (2023)

2.2 Global Anti-inflammatory Medicine for Pets Revenue by Company (2019-2024)

2.3 Global Anti-inflammatory Medicine for Pets Players Sales Volume Ranking (2023)

2.4 Global Anti-inflammatory Medicine for Pets Sales Volume by Company Players (2019-2024)

2.5 Global Anti-inflammatory Medicine for Pets Average Price by Company (2019-2024)

2.6 Key Manufacturers Anti-inflammatory Medicine for Pets Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anti-inflammatory Medicine for Pets Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anti-inflammatory Medicine for Pets

2.9 Anti-inflammatory Medicine for Pets Market Competitive Analysis

2.9.1 Anti-inflammatory Medicine for Pets Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anti-inflammatory Medicine for Pets Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Medicine for Pets as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Powder

3.1.2 Liquid

3.2 Global Anti-inflammatory Medicine for Pets Sales Value by Type

3.2.1 Global Anti-inflammatory Medicine for Pets Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti-inflammatory Medicine for Pets Sales Value, by Type (2019-2030)

3.2.3 Global Anti-inflammatory Medicine for Pets Sales Value, by Type (%) (2019-2030)

3.3 Global Anti-inflammatory Medicine for Pets Sales Volume by Type

3.3.1 Global Anti-inflammatory Medicine for Pets Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anti-inflammatory Medicine for Pets Sales Volume, by Type (2019-2030)

3.3.3 Global Anti-inflammatory Medicine for Pets Sales Volume, by Type (%) (2019-2030)

3.4 Global Anti-inflammatory Medicine for Pets Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cat

4.1.2 Dog

4.1.3 Reptile

4.1.4 Other

4.2 Global Anti-inflammatory Medicine for Pets Sales Value by Application

4.2.1 Global Anti-inflammatory Medicine for Pets Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti-inflammatory Medicine for Pets Sales Value, by Application (2019-2030)

4.2.3 Global Anti-inflammatory Medicine for Pets Sales Value, by Application (%) (2019-2030)

4.3 Global Anti-inflammatory Medicine for Pets Sales Volume by Application

4.3.1 Global Anti-inflammatory Medicine for Pets Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anti-inflammatory Medicine for Pets Sales Volume, by Application (2019-2030)

4.3.3 Global Anti-inflammatory Medicine for Pets Sales Volume, by Application (%) (2019-2030)

4.4 Global Anti-inflammatory Medicine for Pets Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anti-inflammatory Medicine for Pets Sales Value by Region

5.1.1 Global Anti-inflammatory Medicine for Pets Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti-inflammatory Medicine for Pets Sales Value by Region (2019-2024)

5.1.3 Global Anti-inflammatory Medicine for Pets Sales Value by Region (2025-2030)

5.1.4 Global Anti-inflammatory Medicine for Pets Sales Value by Region (%), (2019-2030)

5.2 Global Anti-inflammatory Medicine for Pets Sales Volume by Region

5.2.1 Global Anti-inflammatory Medicine for Pets Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2019-2024)

5.2.3 Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2025-2030)

5.2.4 Global Anti-inflammatory Medicine for Pets Sales Volume by Region (%), (2019-2030)

5.3 Global Anti-inflammatory Medicine for Pets Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

5.4.2 North America Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

5.5.2 Europe Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

5.6.2 Asia Pacific Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

5.7.2 South America Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

5.8.2 Middle East & Africa Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value

6.2.1 Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.3.2 United States Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.4.2 Europe Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.5.2 China Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.6.2 Japan Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.7.2 South Korea Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.8.2 Southeast Asia Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti-inflammatory Medicine for Pets Sales Value, 2019-2030

6.9.2 India Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti-inflammatory Medicine for Pets Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Zoetis

7.1.1 Zoetis Company Information

7.1.2 Zoetis Introduction and Business Overview

7.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Offerings

7.1.5 Zoetis Recent Development

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Company Information

7.2.2 Boehringer Ingelheim Introduction and Business Overview

7.2.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Offerings

7.2.5 Boehringer Ingelheim Recent Development

7.3 Merck

7.3.1 Merck Company Information

7.3.2 Merck Introduction and Business Overview

7.3.3 Merck Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Merck Anti-inflammatory Medicine for Pets Product Offerings

7.3.5 Merck Recent Development

7.4 Elanco

7.4.1 Elanco Company Information

7.4.2 Elanco Introduction and Business Overview

7.4.3 Elanco Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Elanco Anti-inflammatory Medicine for Pets Product Offerings

7.4.5 Elanco Recent Development

7.5 Virbac

7.5.1 Virbac Company Information

7.5.2 Virbac Introduction and Business Overview

7.5.3 Virbac Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Virbac Anti-inflammatory Medicine for Pets Product Offerings

7.5.5 Virbac Recent Development

7.6 Dechra Veterinary Products

7.6.1 Dechra Veterinary Products Company Information

7.6.2 Dechra Veterinary Products Introduction and Business Overview

7.6.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Offerings

7.6.5 Dechra Veterinary Products Recent Development

7.7 Ceva

7.7.1 Ceva Company Information

7.7.2 Ceva Introduction and Business Overview

7.7.3 Ceva Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Ceva Anti-inflammatory Medicine for Pets Product Offerings

7.7.5 Ceva Recent Development

7.8 Vetoquinol

7.8.1 Vetoquinol Company Information

7.8.2 Vetoquinol Introduction and Business Overview

7.8.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Offerings

7.8.5 Vetoquinol Recent Development

7.9 Ouro Fino Saude

7.9.1 Ouro Fino Saude Company Information

7.9.2 Ouro Fino Saude Introduction and Business Overview

7.9.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Offerings

7.9.5 Ouro Fino Saude Recent Development

7.10 Norbrook

7.10.1 Norbrook Company Information

7.10.2 Norbrook Introduction and Business Overview

7.10.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Norbrook Anti-inflammatory Medicine for Pets Product Offerings

7.10.5 Norbrook Recent Development

7.11 Jindun

7.11.1 Jindun Company Information

7.11.2 Jindun Introduction and Business Overview

7.11.3 Jindun Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Jindun Anti-inflammatory Medicine for Pets Product Offerings

7.11.5 Jindun Recent Development

7.12 Wuhan chopperlvya

7.12.1 Wuhan chopperlvya Company Information

7.12.2 Wuhan chopperlvya Introduction and Business Overview

7.12.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Offerings

7.12.5 Wuhan chopperlvya Recent Development

7.13 CAHIC

7.13.1 CAHIC Company Information

7.13.2 CAHIC Introduction and Business Overview

7.13.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)

7.13.4 CAHIC Anti-inflammatory Medicine for Pets Product Offerings

7.13.5 CAHIC Recent Development

8 Industry Chain Analysis

8.1 Anti-inflammatory Medicine for Pets Industrial Chain

8.2 Anti-inflammatory Medicine for Pets Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti-inflammatory Medicine for Pets Sales Model

8.5.2 Sales Channel

8.5.3 Anti-inflammatory Medicine for Pets Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Dechra Veterinary Products

List of Tables

Table 1. Anti-inflammatory Medicine for Pets Market Trends

Table 2. Anti-inflammatory Medicine for Pets Market Drivers & Opportunity

Table 3. Anti-inflammatory Medicine for Pets Market Challenges

Table 4. Anti-inflammatory Medicine for Pets Market Restraints

Table 5. Global Anti-inflammatory Medicine for Pets Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Company (2019-2024)

Table 7. Global Anti-inflammatory Medicine for Pets Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Anti-inflammatory Medicine for Pets Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anti-inflammatory Medicine for Pets Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Anti-inflammatory Medicine for Pets Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anti-inflammatory Medicine for Pets Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anti-inflammatory Medicine for Pets

Table 13. Global Anti-inflammatory Medicine for Pets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Medicine for Pets as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-inflammatory Medicine for Pets Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anti-inflammatory Medicine for Pets Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anti-inflammatory Medicine for Pets Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anti-inflammatory Medicine for Pets Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anti-inflammatory Medicine for Pets Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anti-inflammatory Medicine for Pets Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Anti-inflammatory Medicine for Pets Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Anti-inflammatory Medicine for Pets Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Anti-inflammatory Medicine for Pets Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anti-inflammatory Medicine for Pets Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anti-inflammatory Medicine for Pets Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Anti-inflammatory Medicine for Pets Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Anti-inflammatory Medicine for Pets Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anti-inflammatory Medicine for Pets Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anti-inflammatory Medicine for Pets Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anti-inflammatory Medicine for Pets Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anti-inflammatory Medicine for Pets Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anti-inflammatory Medicine for Pets Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Anti-inflammatory Medicine for Pets Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Anti-inflammatory Medicine for Pets Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Anti-inflammatory Medicine for Pets Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anti-inflammatory Medicine for Pets Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anti-inflammatory Medicine for Pets Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Anti-inflammatory Medicine for Pets Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Anti-inflammatory Medicine for Pets Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anti-inflammatory Medicine for Pets Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anti-inflammatory Medicine for Pets Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anti-inflammatory Medicine for Pets Sales Value by Region (2019-2024) & (%)

Table 44. Global Anti-inflammatory Medicine for Pets Sales Value by Region (2025-2030) & (%)

Table 45. Global Anti-inflammatory Medicine for Pets Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anti-inflammatory Medicine for Pets Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anti-inflammatory Medicine for Pets Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Anti-inflammatory Medicine for Pets Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Volume, (2025-2030) & (K Units)

Table 57. Zoetis Company Information

Table 58. Zoetis Introduction and Business Overview

Table 59. Zoetis Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Zoetis Anti-inflammatory Medicine for Pets Product Offerings

Table 61. Zoetis Recent Development

Table 62. Boehringer Ingelheim Company Information

Table 63. Boehringer Ingelheim Introduction and Business Overview

Table 64. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Offerings

Table 66. Boehringer Ingelheim Recent Development

Table 67. Merck Company Information

Table 68. Merck Introduction and Business Overview

Table 69. Merck Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Merck Anti-inflammatory Medicine for Pets Product Offerings

Table 71. Merck Recent Development

Table 72. Elanco Company Information

Table 73. Elanco Introduction and Business Overview

Table 74. Elanco Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Elanco Anti-inflammatory Medicine for Pets Product Offerings

Table 76. Elanco Recent Development

Table 77. Virbac Company Information

Table 78. Virbac Introduction and Business Overview

Table 79. Virbac Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Virbac Anti-inflammatory Medicine for Pets Product Offerings

Table 81. Virbac Recent Development

Table 82. Dechra Veterinary Products Company Information

Table 83. Dechra Veterinary Products Introduction and Business Overview

Table 84. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Offerings

Table 86. Dechra Veterinary Products Recent Development

Table 87. Ceva Company Information

Table 88. Ceva Introduction and Business Overview

Table 89. Ceva Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Ceva Anti-inflammatory Medicine for Pets Product Offerings

Table 91. Ceva Recent Development

Table 92. Vetoquinol Company Information

Table 93. Vetoquinol Introduction and Business Overview

Table 94. Vetoquinol Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Vetoquinol Anti-inflammatory Medicine for Pets Product Offerings

Table 96. Vetoquinol Recent Development

Table 97. Ouro Fino Saude Company Information

Table 98. Ouro Fino Saude Introduction and Business Overview

Table 99. Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Offerings

Table 101. Ouro Fino Saude Recent Development

Table 102. Norbrook Company Information

Table 103. Norbrook Introduction and Business Overview

Table 104. Norbrook Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Norbrook Anti-inflammatory Medicine for Pets Product Offerings

Table 106. Norbrook Recent Development

Table 107. Jindun Company Information

Table 108. Jindun Introduction and Business Overview

Table 109. Jindun Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Jindun Anti-inflammatory Medicine for Pets Product Offerings

Table 111. Jindun Recent Development

Table 112. Wuhan chopperlvya Company Information

Table 113. Wuhan chopperlvya Introduction and Business Overview

Table 114. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Offerings

Table 116. Wuhan chopperlvya Recent Development

Table 117. CAHIC Company Information

Table 118. CAHIC Introduction and Business Overview

Table 119. CAHIC Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. CAHIC Anti-inflammatory Medicine for Pets Product Offerings

Table 121. CAHIC Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Anti-inflammatory Medicine for Pets Downstream Customers

Table 125. Anti-inflammatory Medicine for Pets Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-inflammatory Medicine for Pets Product Picture

Figure 2. Global Anti-inflammatory Medicine for Pets Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anti-inflammatory Medicine for Pets Sales Volume (2019-2030) & (K Units)

Figure 5. Global Anti-inflammatory Medicine for Pets Sales Price (2019-2030) & (US$/Unit)

Figure 6. Anti-inflammatory Medicine for Pets Report Years Considered

Figure 7. Global Anti-inflammatory Medicine for Pets Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anti-inflammatory Medicine for Pets Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-inflammatory Medicine for Pets Revenue in 2023

Figure 10. Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Powder Picture

Figure 12. Liquid Picture

Figure 13. Global Anti-inflammatory Medicine for Pets Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Anti-inflammatory Medicine for Pets Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Anti-inflammatory Medicine for Pets Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Anti-inflammatory Medicine for Pets Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Anti-inflammatory Medicine for Pets Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Cat

Figure 19. Product Picture of Dog

Figure 20. Product Picture of Reptile

Figure 21. Product Picture of Other

Figure 22. Global Anti-inflammatory Medicine for Pets Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Anti-inflammatory Medicine for Pets Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Anti-inflammatory Medicine for Pets Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Anti-inflammatory Medicine for Pets Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Anti-inflammatory Medicine for Pets Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Anti-inflammatory Medicine for Pets Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Anti-inflammatory Medicine for Pets Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Anti-inflammatory Medicine for Pets Sales Volume (%), (2019-2030)

Figure 39. United States Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 45. China Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 47. China Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 57. India Anti-inflammatory Medicine for Pets Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Anti-inflammatory Medicine for Pets Sales Value by Type (%), 2023 VS 2030

Figure 59. India Anti-inflammatory Medicine for Pets Sales Value by Application (%), 2023 VS 2030

Figure 60. Anti-inflammatory Medicine for Pets Industrial Chain

Figure 61. Anti-inflammatory Medicine for Pets Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions